ArticleCancer medicine2020

Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide.

Kazuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.